Fibronostics
The startup has developed a non-invasive diagnostic testing system that utilizes algorithm-based health monitoring to assess liver disease and chronic conditions such as coronary heart disease and diabetes. This technology enables early detection of disease progression, facilitating timely medical intervention and improved patient outcomes.
- Artificial Intelligence
- Digital Health
- Healthcare Technology
- Software Only
Updated 6 months ago
Funding
Raised to date
$14.8MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup has developed a non-invasive diagnostic testing system that utilizes algorithm-based health monitoring to assess liver disease and chronic conditions such as coronary heart disease and diabetes. This technology enables early detection of disease progression, facilitating timely medical intervention and improved patient outcomes.